Cargando…

Nanoparticles systemically biodistribute to regenerating skeletal muscle in DMD

Skeletal muscle disease severity can often progress asymmetrically across muscle groups and heterogeneously within tissues. An example is Duchenne Muscular Dystrophy (DMD) in which lack of dystrophin results in devastating skeletal muscle wasting in some muscles whereas others are spared or undergo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hicks, Michael R., Liu, Xiangsheng, Young, Courtney S., Saleh, Kholoud, Ji, Ying, Jiang, Jinhong, Emami, Michael R., Mokhonova, Ekaterina, Spencer, Melissa J., Meng, Huan, Pyle, April D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463982/
https://www.ncbi.nlm.nih.gov/pubmed/37641124
http://dx.doi.org/10.1186/s12951-023-01994-0
_version_ 1785098360664883200
author Hicks, Michael R.
Liu, Xiangsheng
Young, Courtney S.
Saleh, Kholoud
Ji, Ying
Jiang, Jinhong
Emami, Michael R.
Mokhonova, Ekaterina
Spencer, Melissa J.
Meng, Huan
Pyle, April D.
author_facet Hicks, Michael R.
Liu, Xiangsheng
Young, Courtney S.
Saleh, Kholoud
Ji, Ying
Jiang, Jinhong
Emami, Michael R.
Mokhonova, Ekaterina
Spencer, Melissa J.
Meng, Huan
Pyle, April D.
author_sort Hicks, Michael R.
collection PubMed
description Skeletal muscle disease severity can often progress asymmetrically across muscle groups and heterogeneously within tissues. An example is Duchenne Muscular Dystrophy (DMD) in which lack of dystrophin results in devastating skeletal muscle wasting in some muscles whereas others are spared or undergo hypertrophy. An efficient, non-invasive approach to identify sites of asymmetry and degenerative lesions could enable better patient monitoring and therapeutic targeting of disease. In this study, we utilized a versatile intravenously injectable mesoporous silica nanoparticle (MSNP) based nanocarrier system to explore mechanisms of biodistribution in skeletal muscle of mdx mouse models of DMD including wildtype, dystrophic, and severely dystrophic mice. Moreover, MSNPs could be imaged in live mice and whole muscle tissues enabling investigation of how biodistribution is altered by different types of muscle pathology such as inflammation or fibrosis. We found MSNPs were tenfold more likely to aggregate within select mdx muscles relative to wild type, such as gastrocnemius and quadriceps. This was accompanied by decreased biodistribution in off-target organs. We found the greatest factor affecting preferential delivery was the regenerative state of the dystrophic skeletal muscle with the highest MSNP abundance coinciding with the regions showing the highest level of embryonic myosin staining and intramuscular macrophage uptake. To demonstrate, muscle regeneration regulated MSNP distribution, we experimentally induced regeneration using barium chloride which resulted in a threefold increase of intravenously injected MSNPs to sites of regeneration 7 days after injury. These discoveries provide the first evidence that nanoparticles have selective biodistribution to skeletal muscle in DMD to areas of active regeneration and that nanoparticles could enable diagnostic and selective drug delivery in DMD skeletal muscle. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-023-01994-0.
format Online
Article
Text
id pubmed-10463982
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104639822023-08-30 Nanoparticles systemically biodistribute to regenerating skeletal muscle in DMD Hicks, Michael R. Liu, Xiangsheng Young, Courtney S. Saleh, Kholoud Ji, Ying Jiang, Jinhong Emami, Michael R. Mokhonova, Ekaterina Spencer, Melissa J. Meng, Huan Pyle, April D. J Nanobiotechnology Research Skeletal muscle disease severity can often progress asymmetrically across muscle groups and heterogeneously within tissues. An example is Duchenne Muscular Dystrophy (DMD) in which lack of dystrophin results in devastating skeletal muscle wasting in some muscles whereas others are spared or undergo hypertrophy. An efficient, non-invasive approach to identify sites of asymmetry and degenerative lesions could enable better patient monitoring and therapeutic targeting of disease. In this study, we utilized a versatile intravenously injectable mesoporous silica nanoparticle (MSNP) based nanocarrier system to explore mechanisms of biodistribution in skeletal muscle of mdx mouse models of DMD including wildtype, dystrophic, and severely dystrophic mice. Moreover, MSNPs could be imaged in live mice and whole muscle tissues enabling investigation of how biodistribution is altered by different types of muscle pathology such as inflammation or fibrosis. We found MSNPs were tenfold more likely to aggregate within select mdx muscles relative to wild type, such as gastrocnemius and quadriceps. This was accompanied by decreased biodistribution in off-target organs. We found the greatest factor affecting preferential delivery was the regenerative state of the dystrophic skeletal muscle with the highest MSNP abundance coinciding with the regions showing the highest level of embryonic myosin staining and intramuscular macrophage uptake. To demonstrate, muscle regeneration regulated MSNP distribution, we experimentally induced regeneration using barium chloride which resulted in a threefold increase of intravenously injected MSNPs to sites of regeneration 7 days after injury. These discoveries provide the first evidence that nanoparticles have selective biodistribution to skeletal muscle in DMD to areas of active regeneration and that nanoparticles could enable diagnostic and selective drug delivery in DMD skeletal muscle. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-023-01994-0. BioMed Central 2023-08-29 /pmc/articles/PMC10463982/ /pubmed/37641124 http://dx.doi.org/10.1186/s12951-023-01994-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Hicks, Michael R.
Liu, Xiangsheng
Young, Courtney S.
Saleh, Kholoud
Ji, Ying
Jiang, Jinhong
Emami, Michael R.
Mokhonova, Ekaterina
Spencer, Melissa J.
Meng, Huan
Pyle, April D.
Nanoparticles systemically biodistribute to regenerating skeletal muscle in DMD
title Nanoparticles systemically biodistribute to regenerating skeletal muscle in DMD
title_full Nanoparticles systemically biodistribute to regenerating skeletal muscle in DMD
title_fullStr Nanoparticles systemically biodistribute to regenerating skeletal muscle in DMD
title_full_unstemmed Nanoparticles systemically biodistribute to regenerating skeletal muscle in DMD
title_short Nanoparticles systemically biodistribute to regenerating skeletal muscle in DMD
title_sort nanoparticles systemically biodistribute to regenerating skeletal muscle in dmd
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463982/
https://www.ncbi.nlm.nih.gov/pubmed/37641124
http://dx.doi.org/10.1186/s12951-023-01994-0
work_keys_str_mv AT hicksmichaelr nanoparticlessystemicallybiodistributetoregeneratingskeletalmuscleindmd
AT liuxiangsheng nanoparticlessystemicallybiodistributetoregeneratingskeletalmuscleindmd
AT youngcourtneys nanoparticlessystemicallybiodistributetoregeneratingskeletalmuscleindmd
AT salehkholoud nanoparticlessystemicallybiodistributetoregeneratingskeletalmuscleindmd
AT jiying nanoparticlessystemicallybiodistributetoregeneratingskeletalmuscleindmd
AT jiangjinhong nanoparticlessystemicallybiodistributetoregeneratingskeletalmuscleindmd
AT emamimichaelr nanoparticlessystemicallybiodistributetoregeneratingskeletalmuscleindmd
AT mokhonovaekaterina nanoparticlessystemicallybiodistributetoregeneratingskeletalmuscleindmd
AT spencermelissaj nanoparticlessystemicallybiodistributetoregeneratingskeletalmuscleindmd
AT menghuan nanoparticlessystemicallybiodistributetoregeneratingskeletalmuscleindmd
AT pyleaprild nanoparticlessystemicallybiodistributetoregeneratingskeletalmuscleindmd